Early transplant related mortality in lymphoma patients undergoing autologous hematopoietic stem cell transplantation after conditioning with CBV (cyclophosphamide, carmustine and etoposide)

被引：0
|
作者：
Regadera, A
Jarque, I
de la Rubia, J
Andreu, R
Garcia, I
Moscardó, F
Mena, A
Yuste, A
Jimenez, C
Martín, G
Martínez, J
Sanz, G
Saavedra, S
Mollá, S
Plumé, G
Sanz, MA
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [31] PHASE-I TRIAL OF DACARBAZINE WITH CYCLOPHOSPHAMIDE, CARMUSTINE, ETOPOSIDE, AND AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MULTIPLE-MYELOMA
    ADKINS, DR
    SALZMAN, D
    BOLDT, D
    KUHN, J
    IRVIN, R
    ROODMAN, GD
    LYONS, R
    SMITH, L
    FREYTES, CO
    LEMAISTRE, CF
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (09) : 1890 - 1901
  • [32] A phase I and pharmacokinetic study of paclitaxel incorporated into the "augmented" high-dose cyclophosphamide, carmustine and etoposide (CBV) as conditioning chemotherapy for autologous stem cell transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Gokmen, E
    Callander, N
    Alexander, J
    Morris, A
    Tsai, TW
    Rosen, DM
    Anderson, J
    Alsina, M
    Craig, F
    Holle, L
    Cruz, J
    Baltathakis, I
    Hilsenbeck, S
    Valley, A
    West, L
    Egorin, MJ
    Freytes, CO
    BLOOD, 1999, 94 (10) : 320B - 320B
  • [33] PEGFILGRASTIM AFTER CONDITIONING WITH BEAM AND AUTOLOGOUS HEMATOPOIETIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN LYMPHOMA PATIENTS
    Loteta, Barbara
    Tripepi, Giovanni
    Annalisa, Pitino
    Gori, Mercedes
    Porto, Gaetana
    Utano, Giovanna
    Policastro, G.
    Santoro, Ludovica
    Mico, Maria Caterina
    Martino, Massimo
    BONE MARROW TRANSPLANTATION, 2024, 59 : 490 - 491
  • [34] Treatment related mortality and overall mortality in patients undergoing autologous hematopoietic stem cell transplantation for autoimmune diseases
    Oyama, Y
    Barr, W
    Cohen, B
    Rosa, R
    Craig, R
    Brieva, J
    Traynor, A
    Bredeson, C
    Lobeck, L
    Burt, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S100 - S100
  • [35] Comparative Analysis of Conditioning Regimens in Patients Undergoing Autologous Hematopoietic STEM CELL Transplant for Lymphoma in a Single Brazilian Center
    Schmidt-Filho, Jayr
    Rayol, Sergio
    Yamaguchi, Marcela
    Atanazio, Marcelo
    Mariano, Livia
    Rossetti, Renata
    Rocha, Vanderson
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [36] Pharmacokinetics of Melphalan in Lymphoma Patients undergoing Beam and Autologous Hematopoietic Stem Cell Transplant
    Dahi, Parastoo
    Lin, Andew
    Flynn, Jessica
    Uruburo, Christian
    Mcgeary, Ian
    Schofield, Ryan
    Bhatt, Valkal
    Derespiris, Lauren
    Figgins, Bradley
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony
    Carlow, Dean
    Cho, Christina
    Lahoud, Oscar
    Perales, Miguel
    Sauter, Craig
    Scordo, Michael
    Shah, Gunjan
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 285 - 286
  • [37] Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma
    Robertson, MJ
    Abonour, R
    Hromas, R
    Nelson, RP
    Fineberg, NS
    Cornetta, K
    LEUKEMIA & LYMPHOMA, 2005, 46 (10) : 1477 - 1487
  • [38] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [39] Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease
    Reece, DE
    Nevill, TJ
    Sayegh, A
    Spinelli, JJ
    Brockington, DA
    Barnett, MJ
    Klingemann, HG
    Connors, JM
    Nantel, SH
    Shepherd, JD
    Sutherland, HJ
    Voss, NJS
    Fairey, RN
    O'Reilly, SE
    Phillips, GL
    BONE MARROW TRANSPLANTATION, 1999, 23 (11) : 1131 - 1138
  • [40] Prolonged survival for patients undergoing autologous stem cell transplant after beam conditioning for primary cns lymphoma
    Johnston, Patrick
    O'Neill, Brian
    Ansell, Stephen
    Inwards, David
    Porrata, Luis
    Micallef, Ivana
    ANNALS OF ONCOLOGY, 2006, 17 : 201 - 202
12345